Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

Summary

The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happens to MK-2828 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.

Timeline

Start

2025-09-22

Primary completion

2026-05-04

Completion

2026-05-04

Drugs

Indications